Morgan Stanley’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.58M | Buy |
|
|||||
|
2025
Q1 | $2.14M | Buy |
|
|||||
|
2024
Q4 | $2.13M | Buy |
|
|||||
|
2024
Q3 | $2.08M | Buy |
|
|||||
|
2024
Q2 | $676K | Buy |
|
|||||
|
2024
Q1 | $490K | Sell |
|
|||||
|
2023
Q4 | $914K | Buy |
|
|||||
|
2023
Q3 | $281K | Buy |
|
|||||
|
2023
Q2 | $320K | Buy |
|
|||||
|
2023
Q1 | $91.1K | Buy |
|
|||||
|
2022
Q4 | $61.7K | Buy |
|
|||||
|
2022
Q3 | $32K | Sell |
|
|||||
|
2022
Q2 | $49K | Buy |
|
|||||
|
2022
Q1 | $67K | Buy |
|
|||||
|
2021
Q4 | $88K | Buy |
|
|||||
|
2021
Q3 | $145K | Sell |
|
|||||
|
2021
Q2 | $99K | Sell |
|
|||||
|
2021
Q1 | $115K | Sell |
|
|||||
|
2020
Q4 | $135K | Buy |
|
|||||
|
2020
Q3 | $131K | Buy |
|
|||||
|
2020
Q2 | $41K | Sell |
|
|||||
|
2020
Q1 | $69K | Sell |
|
|||||
|
2019
Q4 | $210K | Sell |
|
|||||
|
2019
Q3 | $136K | Buy |
|
|||||
|
2019
Q2 | $122K | Sell |
|
|||||
|
2019
Q1 | $230K | Buy |
|
|||||
|
2018
Q4 | $126K | Buy |
|
|||||
|
2018
Q3 | $204K | Sell |
|
|||||
|
2018
Q2 | $340K | Buy |
|
|||||
|
2018
Q1 | $281K | Buy |
|
|||||
|
2017
Q4 | $187K | Buy |
|
|||||
|
2017
Q3 | $226K | Buy |
|
|||||
|
2017
Q2 | $109K | Buy |
|
|||||
|
2017
Q1 | $98K | Sell |
|
|||||
|
2016
Q4 | $142K | Buy |
|
|||||
|
2016
Q3 | $15K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $3K | Buy |
|